Medical Cannabis Reciprocity Explained
Some states recognize visiting patients, some require temporary registration and others offer no reciprocity. Never transport cannabis across state lines based solely on reciprocity assumptions.
Read article →Patient Articles
Medical cannabis, HSA/FSA, patient rights, state programs and reimbursement guidance.
How to Verify That a Cannabis Dispensary Is Licensed
Use the official state regulator’s license search rather than relying only on maps, advertisements, or review sites. Match the business name and address, check license status and expiration,…
Read article →Understanding the Medical Expense Deduction
Eligibility of an expense and the threshold for claiming an itemized medical deduction are separate questions. Taxpayers should use current IRS instructions and professional advice.
Read article →Medical Cannabis Reciprocity: Can You Use an Out-of-State Card?
Reciprocity varies sharply. Some states recognize visiting patients, some require temporary registration, and others provide no purchasing rights to out-of-state cardholders. Possession rules, product limits, and transportation laws…
Read article →What to Include in a Reimbursement Request
A claim package may include the administrator’s form, itemized receipt, proof of payment, physician documentation and a clear statement of medical purpose. Documentation does not convert an ineligible…
Read article →What Records Should Medical Cannabis Patients Keep?
Keep physician certifications, registry records, itemized receipts, proof of payment, product labels when relevant, administrator correspondence, denial notices, and notes showing when information was verified. Never submit altered…
Read article →Federal Rescheduling: What Patients Should Watch
Patients should watch for a final federal rule, its effective date, IRS and Treasury guidance, FDA implications and changes to HSA/FSA administrator policies. State legality and federal treatment…
Read article →Federal Marijuana Rescheduling: What Patients Should Watch
Rescheduling could affect research, business taxation, prescribing pathways, and public policy, but it would not automatically convert every state dispensary product into an FDA-approved prescription drug or every…
Read article →